Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma. - Vasey,P.A.; Jayson,G.C.; Gordon,A.; Gabra,H.; Coleman,R.; Atkinson,R.; Parkin,D.; Paul,J.; Hay,A.; Kaye,S.B. (J Natl Cancer Inst, 2004)